Recognizing Risk and Benefits of Management Options for Aplastic Anemia
											
							This case examines the treatment approaches for aplastic anemia, including immunosuppressant therapy (IST), hematopoietic stem cell transplantation (HSCT), and supportive care. It explores appropriate patient selection based on etiology and other considerations (eg, severity of disease, patient age, etc).